Select a community
All Communities
Home > Community Treatment Reports > Abacavir-Lamivudine Treatment Report
What is Abacavir-Lamivudine?

Abacavir and lamivudine are antiretroviral agents. Both of these medicines are nucleoside reverse transcriptase inhibitors (NRTIs). The combination of abacavir and lamivudine is used for the treatment of HIV infections in combination with other antiretroviral agents.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Treat my HIV 83 16
Support another treatment 3 2
Fatigue 2 1
Night sweats 1 0
Other 1 1
Improve immune function 1 1

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
2 10%
Moderate
3 14%
Mild
5 24%
None
11 52%

Most commonly reported side effects

Fatigue
5 24%
Anxiety
4 19%
Panic attacks
3 14%
Lipodystrophy
3 14%
  • Mild
  • Moderate
  • Severe

Dosages

Top 10 dosages based on patients currently taking Abacavir-Lamivudine. See all 13 dosages ►

  daily 1 daily 1 g daily 1 mg daily 1 tbs. daily 30 mg daily 600 mg-300 mg weekly 200 mg daily 300 mg daily 600 mg-300 mg daily 600 mg daily 900 mg daily 2 x 600 mg-300 mg daily
  5 Number of Patients: 5 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 58 Number of Patients: 58 7 Number of Patients: 7 6 Number of Patients: 6 5 Number of Patients: 5  

Stop Reasons

Why Patients Stopped Taking Abacavir-Lamivudine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe
6 40% Side effects too severe: 40%
Other
4 27% Other: 27%
Doctor's advice
3 20% Doctor's advice: 20%
Personal research
2 13% Personal research: 13%
Did not seem to work
1 7% Did not seem to work: 7%
Not indicated
1 7% Not indicated: 7%

See all 14 patients who’ve stopped taking Abacavir-Lamivudine

Duration See details about how long patients take this treatment ▼

Currently Taking Abacavir-Lamivudine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
1
2
7
16
23

Stopped Taking Abacavir-Lamivudine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
4
0
1
5
3
1

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
19 90%
Usually
1 5%
Sometimes
0 0%
Never
1 5%

Burden

Difficulty being on treatment

Very
1 5%
Somewhat
0 0%
A little
7 33%
Not at all
13 62%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
4 19%
< $25
8 38%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 21, 2009.